International Heart Journal
Online ISSN : 1349-3299
Print ISSN : 1349-2365
ISSN-L : 1349-2365
Clinical Studies
Predictive Model and Risk Score for In-Hospital Mortality in Patients with All-Cause Cardiogenic Shock
Santiago Shock Score (S3)
Federico García-Rodeja AriasMarta Alonso-Fernandez-GattaMarta Pérez DominguezJesús Martinón MartínezPedro Rigueiro VelosoRosa María Agra BermejoDiego Iglesias ÁlvarezSoraya Merchán-GómezAlejandro Diego-NietoCharigán Abou Jokh CasasBelén Álvarez ÁlvarezTeba González FerreroCarla Cacho AntonioPablo José Antúnez MuiñosJosé María García AcuñaPedro L SánchezJosé Ramón González Juanatey
Author information
JOURNAL FREE ACCESS
Supplementary material

2022 Volume 63 Issue 6 Pages 1034-1040

Details
Abstract

Cardiogenic shock (CS) is a condition associated with high morbidity and mortality. Our study aimed to perform a risk score for in-hospital mortality that allows for stratifying the risk of death in patients with CS.

This is a retrospective analysis, which included 135 patients from a Spanish university hospital between 2011 and 2020. The Santiago Shock Score (S3) was created using clinical, analytical, and echocardiographic variables obtained at the time of admission.

The in-hospital mortality rate was 41.5%, and acute coronary syndrome (ACS) was the responsible cause of shock in 60.7% of patients. Mitral regurgitation grade III-IV, age, ACS etiology, NT-proBNP, blood hemoglobin, and lactate at admission were included in the score. The S3 had good accuracy for predicting in-hospital mortality area under the receiver operating characteristic curve (AUC) 0.85 (95% confidence interval (CI) 0.78-0.90), higher than the AUC of the CardShock score, which was 0.74 (95% CI 0.66-0.83). Predictive power in a cohort of 131 patients with profound CS was similar to that of CardShock with an AUC of 0.601 (95% CI 0.496-0.706) versus an AUC of 0.558 (95% CI 0.453-0.664). Three risk categories were created according to the S3: low (scores 0-6), intermediate (scores 7-10), and high (scores 11-16) risks, with an observed mortality of 12.9%, 49.1%, and 87.5% respectively (P < 0.001).

The S3 score had excellent predictive power for in-hospital mortality in patients with nonprofound CS. It could aid the initial risk stratification of patients and thus, guide treatment and clinical decision making in patients with CS.

Content from these authors
© 2022 by the International Heart Journal Association
Previous article Next article
feedback
Top